THE WORLD’S FIRST PRACTICAL METHOD FOR MEASURING THE BRAIN FUNCTION OF INTENSIVE CARE PATIENTS

INTRODUCING A NEW METHOD TO READTHE PULSE OF THE BRAIN™

Our CERENION C-TREND™ technology (pat. pend.) reveals the status of the brain as one simple score – at the bed-side and without requiring any changes to the care of the patient.

From strong science to better healthcare

CERENION C-TREND™ offers the first truly objective and practical method to obtain reliable information on the condition and function of the brain. The clinically validated measure can be integrated into EEG-measurement devices and patient monitors as a software feature.

CERENION C-TREND™ is a medical-grade software solution that works by combining standard EEG-measurement with advanced machine learning algorithms and artificial intelligence. The result is a simple index that measures the condition and function of the brain on a scale from 0 to 100.

The technology has the potential of improving both the quality and the cost of intensive care.

Easy interpretation

Fast setup

Continuousmonitoring

Our patented technology in your devices

CERENION C-TREND™ will be integrated into a range of products made by our partner companies. The first partner product offerings featuring CERENION C-TREND™ technology are expected to be launched in 2019 in the European Union.

If you are interested about including our technology in your devices please contact us for more information.

"There are currently no reliable methods for assessing brain function in the early stages of recovery from hypoxic, ischemic, or traumatic insults that might inform neurologic prognosis and therapy. Slow electroencephalographic waves induced by general anesthetics might provide a neurophysiologic signature of healthy brain function."